☆ 4.7 Letter

Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY

Volume 134, Issue 5, Pages 1468-1470

Publisher

NATURE PUBLISHING GROUP

DOI: 10.1038/jid.2013.378

Keywords

-

Categories

Dermatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.